Plasma equol concentration is not associated with breast cancer and fibrocystic breast conditions among women in Shanghai, China

Equol (a bacterial metabolite of the soy isoflavone daidzein) is produced by 30-50% of humans and may be associated with health outcomes. We hypothesized that plasma equol would be inversely associated with risks of fibrocystic breast conditions (FBC) and breast cancer (BC). Plasma from women in a breast self-examination trial in Shanghai with BC (n=269) or FBC (n=443), and age-matched controls (n=1027) was analyzed for isoflavones. Equol was grouped into categories (

http://www.nrjournal.com/article/S0271-5317(16)30004-5/abstract?rss=yes

Source: Nutrition Research - March 29, 2016 Category: Nutrition Authors: Charlotte Atkinson, Roberta M. Ray, Wenjin Li, Ming-Gang Lin, Dao Li Gao, Jackilen Shannon, Helge Stalsberg, Peggy L. Porter, Cara L. Frankenfeld, Kristiina Wähälä, David B. Thomas, Johanna W. Lampe Source Type: research